Dec'05 | Dec'06 | Dec'07 | Dec'08 | Jan'10 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Capital Employed (ROCE) | 15.3% | 7.5% | 32.2% | 24.8% | 21.8% | 65.3% | 32.1% | 14.9% | 17.0% | 13.5% | 11.4% | 11.6% | 11.4% | 12.6% | 12.4% | 10.1% | 11.5% | 9.4% | 11.4% | 8.2% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Return on Capital Employed (ROCE) is 11.5%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Return on Capital Employed (ROCE) for Encompass Health Corporation have been 10.1% over the past three years, and 9.9% over the past five years.
As of today, Encompass Health Corporation's Return on Capital Employed (ROCE) is 11.5%, which is higher than industry median of 3.5%. It indicates that Encompass Health Corporation's Return on Capital Employed (ROCE) is Good.